Diabetes Core Update October 2023 | American Diabetes Association
Podcast Type: 
Diabetes Core
Publication Date: 
Tuesday, September 26, 2023 - 00:00
Neil S. Skolnik, MD and John J. Russell, MD

Post Date: September 26, 2023
Total Time: 37:57 | File Size: 52 MB

Articles Covered in this Edition

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity. Kosiborod et al. N Engl J Med. 2023;389(12):1069–1084. https://www.nejm.org/doi/10.1056/NEJMoa2306963.

Real-world Accuracy of CGM in Inpatient Critical and Noncritical Care Settings at a Safety-Net Hospital. Finn et al. Diabetes Care 2023;46(10):1825–1830. https://doi.org/10.2337/dc23-0089.

Leisure-Time Physical Activity and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A UK Biobank Study. Kristensen et al. Diabetes Care 2023;46(10):1816–1824. https://doi.org/10.2337/dc23-0937.

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function. Herold et al. Diabetes Care 2023;46(10):1848–1856. https://doi.org/10.2337/dc23-0675.

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Wharton et al. N Engl J Med. 2023;389(10):877–888. https://www.nejm.org/doi/10.1056/NEJMoa2302392.

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes. Moura et al. Diabetes Care 2023;46(10):1807–1815. https://doi.org/10.2337/dc23-0492.